lippard glutathione cisplatin A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer New drug candidate shows promise

V-9302, a competitive small-molecule antagonist of transmembrane glutamine flux, leads to reduced cancer cell growth and proliferation, increased cell death, and increased oxidative stress through the pharmacological blockade of ASCT2, and these activities together promote antitumor responses in vitro and in vivo [180]

To investigate in vitro chondrogenic differentiation, the BMSC pellet culture test was performed

Or call us directly:201-729-0001 Medical Disclaimer: This article is for educational purposes only and does not replace a consultation with a qualified medical provider

Licensed telehealth platforms must verify patient identity using government-issued ID, conduct comprehensive psychiatric evaluations lasting 30-45 minutes, and maintain DEA-compliant prescription records for all controlled substance prescriptions